Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA061232-04
Application #
2101961
Study Section
Special Emphasis Panel (SRC (56))
Project Start
1993-07-01
Project End
1997-06-30
Budget Start
1996-07-01
Budget End
1997-06-30
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
149617367
City
Boston
State
MA
Country
United States
Zip Code
02215
Liang, P; Pardee, A B (1998) Differential display. A general protocol. Mol Biotechnol 10:261-7
Zhao, S; Molnar, G; Zhang, J et al. (1998) 3'-end cDNA pool suitable for differential display from a small number of cells. Biotechniques 24:842-50, 852
Biswas, D K; Averboukh, L; Sheng, S et al. (1998) Classification of breast cancer cells on the basis of a functional assay for estrogen receptor. Mol Med 4:454-67
Liang, P; Pardee, A B (1997) Differential display. A general protocol. Methods Mol Biol 85:3-11
Zhang, R; Zhang, H; Zhu, W et al. (1997) Mob-1, a Ras target gene, is overexpressed in colorectal cancer. Oncogene 14:1607-10
Zhao, S; Ooi, S L; Yang, F C et al. (1996) Three methods for identification of true positive cloned cDNA fragment in differential display. Biotechniques 20:400-4
Rohrwild, M; Alpan, R S; Liang, P et al. (1995) Inosine-containing primers for mRNA differential display. Trends Genet 11:300
Zhao, S; Ooi, S L; Pardee, A B (1995) New primer strategy improves precision of differential display. Biotechniques 18:842-6, 848, 850
Liang, P; Pardee, A B (1995) Recent advances in differential display. Curr Opin Immunol 7:274-80